A number of drug companies are fighting a request to produce documents involving reports linking pancreatic cancer to use of their type 2 diabetes treatments. Defendants Merck Sharp & Dohme Corp., Eli Lilly, Novo Nordisk, and Amylin Pharmaceuticals told a California federal court that gathering the requested information would be an “unreasonably burdensome fishing expedition.” Plaintiffs already have adverse events reports but are now seeking source files including underlying medical records of individual patients used to compile the reports. The motion is the most recent development in a multidistrict litigation against the drug companies that manufacture and distribute a newer ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.